Publication:
Exploring real-world prescribing patterns for maintenance treatment in bipolar disorders: a focus on antidepressants and benzodiazepines

dc.contributor.authorAndric Petrovic, Sanja (55488423700)
dc.contributor.authorJankovic, Dusan (59312906700)
dc.contributor.authorKaurin, Nina (58549928900)
dc.contributor.authorMandic Maravic, Vanja (56663255900)
dc.contributor.authorPesic, Danilo (55582296200)
dc.contributor.authorRistic, Ivan (57191339222)
dc.contributor.authorMaric, Nadja P. (57226219191)
dc.date.accessioned2025-06-12T11:50:12Z
dc.date.available2025-06-12T11:50:12Z
dc.date.issued2024
dc.description.abstractObjective: Bipolar disorders (BD) are characterized by highly recurrent nature, necessitating adequate maintenance treatment for long-term disorder control. This study aimed to investigate real-world prescribing patterns among outpatients with BD, focusing on the utilisation of antidepressants (AD) and benzodiazepines (BDZ). Methods: We analysed prescription patterns of the five main groups of psychotropic medications (antipsychotics, mood stabilizers, AD, BDZ, and anticholinergic medications) and their relationships with basic socio-demographic and clinical data in a sample of 107 clinically stable BD outpatients (75.7% female, age 44.8 ± 11.7). Results: Maintenance therapy predominantly involved polypharmacy (92.5%), with mood stabilizers (87.9%) and antipsychotics (80.4%, predominantly second-generation) being the most commonly prescribed. Our findings highlight a high percentage of patients prescribed AD (50.5%) and BDZ (54.2%). BDZ patients, compared to the non-BDZ group in maintenance treatment, were significantly older with longer psychiatric history and a decreased likelihood of comorbid personality disorder diagnoses. Conclusions: This study offers insights into prescribing practices within a university psychiatric clinic in the Western Balkans. The prevalent use of polypharmacy in real-world clinical settings, along with high percentage of patients prescribed AD and BDZ, suggests a gap between guideline recommendations and clinical practice, indicating a lack of consensus or standardized approaches in clinical practice. © 2024 Informa UK Limited, trading as Taylor & Francis Group.
dc.identifier.urihttps://doi.org/10.1080/13651501.2024.2398796
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85203066953&doi=10.1080%2f13651501.2024.2398796&partnerID=40&md5=0550cfa6b40768bd4c15ea218b0b19e6
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/1436
dc.subjectantidepressants
dc.subjectbenzodiazepines
dc.subjectBipolar disorders
dc.subjectmaintenance treatment
dc.subjectprescribing guidelines
dc.titleExploring real-world prescribing patterns for maintenance treatment in bipolar disorders: a focus on antidepressants and benzodiazepines
dspace.entity.typePublication

Files